NO985339D0 - Human B cell antigens and related reagents - Google Patents
Human B cell antigens and related reagentsInfo
- Publication number
- NO985339D0 NO985339D0 NO985339A NO985339A NO985339D0 NO 985339 D0 NO985339 D0 NO 985339D0 NO 985339 A NO985339 A NO 985339A NO 985339 A NO985339 A NO 985339A NO 985339 D0 NO985339 D0 NO 985339D0
- Authority
- NO
- Norway
- Prior art keywords
- human
- cell antigens
- related reagents
- reagents
- antigens
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Veterinary Medicine (AREA)
- Analytical Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64955396A | 1996-05-17 | 1996-05-17 | |
| PCT/US1997/007648 WO1997044452A1 (en) | 1996-05-17 | 1997-05-15 | Human b-cell antigens, related reagents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO985339D0 true NO985339D0 (en) | 1998-11-16 |
| NO985339L NO985339L (en) | 1999-01-15 |
Family
ID=24605301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO985339A NO985339L (en) | 1996-05-17 | 1998-11-16 | Human B cell antigens and related reagents |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0910636A1 (en) |
| JP (1) | JP2000514281A (en) |
| KR (1) | KR20000011101A (en) |
| AU (1) | AU722499B2 (en) |
| BR (1) | BR9710968A (en) |
| CA (1) | CA2254843A1 (en) |
| CZ (1) | CZ365098A3 (en) |
| IL (1) | IL126811A0 (en) |
| NO (1) | NO985339L (en) |
| NZ (1) | NZ332598A (en) |
| PL (1) | PL329930A1 (en) |
| SK (1) | SK157498A3 (en) |
| WO (1) | WO1997044452A1 (en) |
Families Citing this family (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7434996A (en) * | 1995-10-19 | 1997-05-07 | Smithkline Beecham Corporation | A novel human b cell surface molecule |
| SI1725249T1 (en) | 2003-11-06 | 2014-04-30 | Seattle Genetics, Inc. | Monomethylvaline compounds capable of conjugation to ligands |
| EP2286844A3 (en) | 2004-06-01 | 2012-08-22 | Genentech, Inc. | Antibody-drug conjugates and methods |
| WO2006034488A2 (en) | 2004-09-23 | 2006-03-30 | Genentech, Inc. | Cysteine engineered antibodies and conjugates |
| US20100111856A1 (en) | 2004-09-23 | 2010-05-06 | Herman Gill | Zirconium-radiolabeled, cysteine engineered antibody conjugates |
| AU2010292172A1 (en) | 2009-09-09 | 2012-05-03 | Centrose, Llc | Extracellular targeted drug conjugates |
| PE20130342A1 (en) | 2010-04-15 | 2013-04-20 | Spirogen Sarl | PIRROLOBENZODIACEPINES AND CONJUGATES OF THE SAME |
| EP2579897A1 (en) | 2010-06-08 | 2013-04-17 | Genentech, Inc. | Cysteine engineered antibodies and conjugates |
| ES2544608T3 (en) | 2010-11-17 | 2015-09-02 | Genentech, Inc. | Antibody and alaninyl-maitansinol conjugates |
| CA2833212C (en) | 2011-05-12 | 2020-06-09 | Genentech, Inc. | Multiple reaction monitoring lc-ms/ms method to detect therapeutic antibodies in animal samples using framework signature peptides |
| HUE025661T2 (en) | 2011-10-14 | 2016-04-28 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
| WO2013130093A1 (en) | 2012-03-02 | 2013-09-06 | Genentech, Inc. | Biomarkers for treatment with anti-tubulin chemotherapeutic compounds |
| MX364328B (en) | 2012-10-12 | 2019-04-23 | Medimmune Ltd | Pyrrolobenzodiazepine-antibody conjugates. |
| NZ707486A (en) | 2012-10-12 | 2018-09-28 | Adc Therapeutics Sa | Pyrrolobenzodiazepine - anti-psma antibody conjugates |
| PL2766048T3 (en) | 2012-10-12 | 2015-05-29 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
| WO2014057114A1 (en) | 2012-10-12 | 2014-04-17 | Adc Therapeutics Sàrl | Pyrrolobenzodiazepine-anti-psma antibody conjugates |
| EP2906297B1 (en) | 2012-10-12 | 2017-12-06 | ADC Therapeutics SA | Pyrrolobenzodiazepine-antibody conjugates |
| NZ707534A (en) | 2012-10-12 | 2018-08-31 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
| DK2906251T3 (en) | 2012-10-12 | 2017-11-20 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-anti-CD22-antibody conjugates |
| CA2894959C (en) | 2012-12-21 | 2022-01-11 | Spirogen Sarl | Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases |
| CN110452242A (en) | 2012-12-21 | 2019-11-15 | 麦迪穆有限责任公司 | Pyrrolobenzodiazepines Zhuo and its conjugate |
| CN105142674B (en) | 2013-03-13 | 2018-11-13 | 麦迪穆有限责任公司 | Pyrrolobenzodiazepines Zhuo and its conjugate |
| US20160031887A1 (en) | 2013-03-13 | 2016-02-04 | Medimmune Limited | Pyrrolobenzodiazepines and conjugates thereof |
| AU2014244245C1 (en) | 2013-03-13 | 2018-04-19 | Genentech, Inc. | Pyrrolobenzodiazepines and conjugates thereof |
| EA201690195A1 (en) | 2013-08-12 | 2016-05-31 | Дженентек, Инк. | ANTIBODY CONJUGATE CONNECTIONS ON THE BASIS OF DIMER 1- (HLORMETHYL) -2,3-DIGYDRO-1H-BENZO [E] INDOL AND METHODS OF APPLICATION AND TREATMENT |
| WO2015052534A1 (en) | 2013-10-11 | 2015-04-16 | Spirogen Sàrl | Pyrrolobenzodiazepine-antibody conjugates |
| EP3054986B1 (en) | 2013-10-11 | 2019-03-20 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| GB201317982D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
| US10010624B2 (en) | 2013-10-11 | 2018-07-03 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| EP3082875B1 (en) | 2013-12-16 | 2020-11-25 | Genentech, Inc. | Peptidomimetic compounds and antibody-drug conjugates thereof |
| CN105873614B (en) | 2013-12-16 | 2020-10-30 | 基因泰克公司 | Peptidomimetic compounds and antibody-drug conjugates thereof |
| MX2016007578A (en) | 2013-12-16 | 2016-10-03 | Genentech Inc | 1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment. |
| EP3193940A1 (en) | 2014-09-10 | 2017-07-26 | Medimmune Limited | Pyrrolobenzodiazepines and conjugates thereof |
| GB201416112D0 (en) | 2014-09-12 | 2014-10-29 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
| WO2016040825A1 (en) | 2014-09-12 | 2016-03-17 | Genentech, Inc. | Anthracycline disulfide intermediates, antibody-drug conjugates and methods |
| AR101844A1 (en) | 2014-09-12 | 2017-01-18 | Genentech Inc | ANTIBODIES AND GENETICALLY MODIFIED CONJUGATES WITH CYSTEINE |
| JP2017533887A (en) | 2014-09-17 | 2017-11-16 | ジェネンテック， インコーポレイテッド | Pyrrolobenzodiazepines and their antibody disulfide conjugates |
| KR20170101895A (en) | 2014-11-25 | 2017-09-06 | 에이디씨 테라퓨틱스 에스에이 | Pyrrolobenzodiazepine-antibody conjugates |
| KR20170086121A (en) | 2014-12-03 | 2017-07-25 | 제넨테크, 인크. | Quaternary amine compounds and antibody-drug conjugates thereof |
| GB201506411D0 (en) | 2015-04-15 | 2015-05-27 | Bergenbio As | Humanized anti-axl antibodies |
| GB201506402D0 (en) | 2015-04-15 | 2015-05-27 | Berkel Patricius H C Van And Howard Philip W | Site-specific antibody-drug conjugates |
| MA43345A (en) | 2015-10-02 | 2018-08-08 | Hoffmann La Roche | PYRROLOBENZODIAZEPINE ANTIBODY-DRUG CONJUGATES AND METHODS OF USE |
| MA43354A (en) | 2015-10-16 | 2018-08-22 | Genentech Inc | CONJUGATE DRUG CONJUGATES WITH CLOUDY DISULPHIDE |
| MA45326A (en) | 2015-10-20 | 2018-08-29 | Genentech Inc | CALICHEAMICIN-ANTIBODY-DRUG CONJUGATES AND METHODS OF USE |
| GB201601431D0 (en) | 2016-01-26 | 2016-03-09 | Medimmune Ltd | Pyrrolobenzodiazepines |
| GB201602356D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| GB201602359D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| JP6943872B2 (en) | 2016-03-25 | 2021-10-06 | ジェネンテック， インコーポレイテッド | Multiple whole antibody and antibody complex drug quantification assay |
| GB201607478D0 (en) | 2016-04-29 | 2016-06-15 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| PL3458101T3 (en) | 2016-05-20 | 2021-05-31 | F. Hoffmann-La Roche Ag | Protac antibody conjugates and methods of use |
| JP7022080B2 (en) | 2016-05-27 | 2022-02-17 | ジェネンテック， インコーポレイテッド | Biochemical analytical methods for the characterization of site-specific antibody-drug conjugates |
| US10639378B2 (en) | 2016-06-06 | 2020-05-05 | Genentech, Inc. | Silvestrol antibody-drug conjugates and methods of use |
| EP3496763A1 (en) | 2016-08-11 | 2019-06-19 | Genentech, Inc. | Pyrrolobenzodiazepine prodrugs and antibody conjugates thereof |
| WO2018065501A1 (en) | 2016-10-05 | 2018-04-12 | F. Hoffmann-La Roche Ag | Methods for preparing antibody drug conjugates |
| GB201617466D0 (en) | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
| AU2018217926B2 (en) | 2017-02-08 | 2019-10-03 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
| GB201702031D0 (en) | 2017-02-08 | 2017-03-22 | Medlmmune Ltd | Pyrrolobenzodiazepine-antibody conjugates |
| EP3612537B1 (en) | 2017-04-18 | 2022-07-13 | Medimmune Limited | Pyrrolobenzodiazepine conjugates |
| US20200129637A1 (en) | 2017-04-20 | 2020-04-30 | Adc Therapeutics Sa | Combination therapy with an anti-axl antibody-drug conjugate |
| KR102442736B1 (en) | 2017-06-14 | 2022-09-16 | 에이디씨 테라퓨틱스 에스에이 | Dosage regime for administration of anti-CD19 ADCs |
| JP7220203B2 (en) | 2017-08-18 | 2023-02-09 | メドイミューン・リミテッド | pyrrolobenzodiazepine complex |
| IL273387B2 (en) | 2017-09-20 | 2023-10-01 | Ph Pharma Co Ltd | Thailanstatin analogs |
| GB201803342D0 (en) | 2018-03-01 | 2018-04-18 | Medimmune Ltd | Methods |
| GB201806022D0 (en) | 2018-04-12 | 2018-05-30 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
| GB201814281D0 (en) | 2018-09-03 | 2018-10-17 | Femtogenix Ltd | Cytotoxic agents |
| EP3870235A1 (en) | 2018-10-24 | 2021-09-01 | F. Hoffmann-La Roche AG | Conjugated chemical inducers of degradation and methods of use |
| CN113227119A (en) | 2018-12-10 | 2021-08-06 | 基因泰克公司 | Photocrosslinked peptides for site-specific conjugation to Fc-containing proteins |
| GB201901197D0 (en) | 2019-01-29 | 2019-03-20 | Femtogenix Ltd | G-A Crosslinking cytotoxic agents |
| GB2597532A (en) | 2020-07-28 | 2022-02-02 | Femtogenix Ltd | Cytotoxic compounds |
| WO2024138128A2 (en) | 2022-12-23 | 2024-06-27 | Genentech, Inc. | Cereblon degrader conjugates, and uses thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5707829A (en) * | 1995-08-11 | 1998-01-13 | Genetics Institute, Inc. | DNA sequences and secreted proteins encoded thereby |
-
1997
- 1997-05-15 CA CA002254843A patent/CA2254843A1/en not_active Abandoned
- 1997-05-15 BR BR9710968-1A patent/BR9710968A/en unknown
- 1997-05-15 KR KR1019980709260A patent/KR20000011101A/en not_active Application Discontinuation
- 1997-05-15 AU AU30599/97A patent/AU722499B2/en not_active Ceased
- 1997-05-15 EP EP97925468A patent/EP0910636A1/en not_active Withdrawn
- 1997-05-15 NZ NZ332598A patent/NZ332598A/en unknown
- 1997-05-15 IL IL12681197A patent/IL126811A0/en unknown
- 1997-05-15 PL PL97329930A patent/PL329930A1/en unknown
- 1997-05-15 WO PCT/US1997/007648 patent/WO1997044452A1/en not_active Application Discontinuation
- 1997-05-15 CZ CZ983650A patent/CZ365098A3/en unknown
- 1997-05-15 JP JP09542423A patent/JP2000514281A/en active Pending
- 1997-05-15 SK SK1574-98A patent/SK157498A3/en unknown
-
1998
- 1998-11-16 NO NO985339A patent/NO985339L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ365098A3 (en) | 1999-06-16 |
| CA2254843A1 (en) | 1997-11-27 |
| IL126811A0 (en) | 1999-08-17 |
| BR9710968A (en) | 2001-09-04 |
| SK157498A3 (en) | 1999-10-08 |
| NZ332598A (en) | 2000-04-28 |
| WO1997044452A1 (en) | 1997-11-27 |
| PL329930A1 (en) | 1999-04-26 |
| AU3059997A (en) | 1997-12-09 |
| JP2000514281A (en) | 2000-10-31 |
| KR20000011101A (en) | 2000-02-25 |
| AU722499B2 (en) | 2000-08-03 |
| NO985339L (en) | 1999-01-15 |
| EP0910636A1 (en) | 1999-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO985339D0 (en) | Human B cell antigens and related reagents | |
| NO20000343L (en) | Mammalian cytokine: interleukin-B30 and related reagents | |
| IS5158A (en) | Genetic separators and methods | |
| NO973107D0 (en) | Programmed cell death genes and proteins | |
| IS4481A (en) | Dihydropyramidine and their use | |
| DE69805292D1 (en) | SHAVING DEVICE AND METHOD | |
| DK0915880T3 (en) | Azolotriazines and pyrimidines | |
| NO20000700L (en) | Interleukin-18 proteins and their preparation and use | |
| DK0894135T3 (en) | Multivalent and multispecific antigen binding protein | |
| DE69807210D1 (en) | SECURED MULTIPURPOSE CARD SYSTEM AND METHOD | |
| NO20071415L (en) | OB fusion protein preparations and methods | |
| DE69715584T2 (en) | Imaging device and method | |
| DK0804078T3 (en) | Composition and use thereof | |
| NO995324L (en) | Carries for objects and subject matter | |
| NO994996L (en) | Improved cell construction for a trawling system and methods | |
| EE200000181A (en) | Identification device and method | |
| DE59809826D1 (en) | BAKING DEVICE AND METHOD | |
| NO983082D0 (en) | Method and device for energy development | |
| NO985806L (en) | Chitinase Materials and Methods | |
| NO971505D0 (en) | Trophine and trophine helper proteins | |
| DE59805515D1 (en) | ASSERVATION AND COLLECTING DEVICE | |
| NO20003268D0 (en) | Hyperhydrated chiticoline, method and use | |
| DE69815434D1 (en) | Imaging device and method | |
| BR9503576A (en) | Battery and charger-charger set | |
| DK1042286T3 (en) | Gamma-glutamyl- and beta-aspartyl-containing immunomodulatory compounds and associated methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |